As of 2025-05-22, the Fair Value of Aptose Biosciences Inc (APS.TO) is -20.20 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.37 CAD, the upside of Aptose Biosciences Inc is -952.31%.
With the market price of 2.37 CAD and our fair value calculation, Aptose Biosciences Inc (APS.TO) is not a good investment. Investing in APS.TO stocks now will result in a potential loss of 952.31%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -26.28 | -55.24 | -65.35 | -41.82 | -51.21 | -47.98 |
| YoY growth | 8.97% | -110.20% | -18.30% | 36.01% | -22.45% | -21.19% |
| Market Cap (mil) | 2.68 |
| P/E | |
| Forward P/E |
| EPS | -2.89 |
| Avg earnings growth rate | -21.19% |
| TTM earnings | -47.17 |